ARTICLE | Clinical News
Glivec: Pilot data; NDA filed in CML
April 9, 2001 7:00 AM UTC
In a U.S. pilot trial of Glivec in 58 patients with blast-phase CML or Ph+ ALL, 21 of 38 CML patients responded to treatment, with 4 patients showing a complete hematologic response. In ALL patients, ...